Pot stocks CRUSHED: Here's what you need to know

The Auscann Group Holdings Ltd (ASX:AC8) share price is down and a number of other pot stocks are being crushed today. Here's what you need to know…

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has not been a great day to be a shareholder of Australia's leading pot stocks. After several weeks of highs, it seems as though many investors have exited the space in a hurry.

Here is the state of play in the industry today:

The Auscann Group Holdings Ltd (ASX: AC8) share price has dropped 5.5% to 59 cents. Today's decline means the pot stock has lost around 34% of its value in the last 30 days.

The Creso Pharma Ltd (ASX: CPH) share price is down 6.5% to 58.5 cents despite the release of a positive announcement. This morning Creso Pharma announced that it had imported the first medicinal cannabis products into Australia under new government legislation.

The MMJ Phytotech Ltd (ASX: MMJ) share price has fallen 17% to 49 cents despite a huge rally overnight in the shares of its Canada-listed 60%-owned Harvest One Cannabis.

The MGC Pharmaceuticals Ltd (ASX: MXC) share price has dropped 3.5% to 6 cents even though it announced a strategic agreement with the Royal Melbourne Institute of Technology. The two parties will collaborate on a full suite of medicinal cannabis research initiatives, initially centred on genetics and cultivation.

The Stemcell United Ltd (ASX: SCU) share price has fallen 20% to 16 cents despite there being no news out of the company. Big share price movements on no news are nothing new for Stemcell United. Yesterday its shares jumped 41% without reason, prompting an ASX price query.

The Zelda Therapeutics Ltd (ASX: ZLD) share price has dropped 9% to 9.1 cents. Today's decline has almost wiped out all of the strong gains it made in April after it announced plans to expand its clinical trials in Chile.

Overall, I believe today's declines show just how volatile the industry can be for investors at this point in time. Whilst one or two of these companies may well go on to greater things, I believe investors are better off watching from the sidelines for the time being.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »